The import of sulphonamides to the US has demonstrated a consistent upward trend from 2024 to 2028, with each year's value gradually increasing. The figures suggest modest annual growth, indicating sustained demand in the market. In 2023, the actual imports stood at X Billion US Dollars, providing a base from which future projections have been calculated. The compound annual growth rate (CAGR) over the five-year forecast period indicates a steady increase, reflective of the growing usage and need within the healthcare and pharmaceutical sectors.

Looking ahead, several factors could influence the trajectory of sulphonamide imports:

Regulatory changes in pharmaceutical and healthcare policies that could impact production or demand.
Technological advancements in drug manufacturing that could alter demand and supply dynamics.
Global supply chain stability, which might affect pricing and import capacities.
Shifts in healthcare expenditure priorities, influencing import volumes.